Viewpoint Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$228K Buy
1,568
+36
+2% +$4.98K 0.11% 99
2026
Q2
$197K Sell
1,532
-2,012
-57% -$236K 0.1% 92
2026
Q1
$426K Buy
3,544
+1
+0% +$115 0.2% 72
2025
Q4
$373K Sell
3,543
-28
-0.8% -$2.63K 0.16% 81
2025
Q3
$300K Buy
3,571
+32
+0.9% +$2.64K 0.13% 87
2025
Q2
$280K Sell
3,539
-246
-6% -$19.6K 0.14% 86
2025
Q1
$340K Buy
3,785
+15
+0.4% +$1.4K 0.18% 83
2024
Q4
$375K Hold
3,770
– – 0.2% 75
2024
Q3
$429K Hold
3,770
– – 0.24% 68
2024
Q2
$467K Buy
3,770
+253
+7% +$32.6K 0.29% 61
2024
Q1
$464K Hold
3,517
– – 0.3% 61
2023
Q4
$383K Hold
3,517
– – 0.27% 66
2023
Q3
$362K Hold
3,517
– – 0.29% 65
2023
Q2
$406K Buy
3,517
+1,050
+43% +$119K 0.31% 61
2023
Q1
$262K Hold
2,467
– – 0.24% 72
2022
Q4
$274K Hold
2,467
– – 0.26% 70
2022
Q3
$212K Hold
2,467
– – 0.21% 74
2022
Q2
$225K Hold
2,467
– – 0.21% 73
2022
Q1
$202K Buy
+2,467
New +$195K 0.16% 84

Other funds holding MRK

Viewpoint Capital Management's MRK Position: Q3 2026 in Review

Viewpoint Capital Management increased its Merck (MRK) stake by 2.3% in Q3 2026, buying an estimated $4.98K and bringing the position to 1,568 shares worth $228K. The position accounts for 0.11% of the portfolio, ranked #99.

Viewpoint Capital Management first reported a position in MRK in Q1 2022 and has held it in 19 quarters since. The position peaked at $467K in Q2 2024. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Viewpoint Capital Management held 1,568 shares of Merck worth $228K as of Q3 2026.
  • Viewpoint Capital Management bought 36 Merck shares in Q3 2026, an estimated $4.98K.
  • Merck made up 0.11% of Viewpoint Capital Management's portfolio in Q3 2026, its #99 holding.
  • Viewpoint Capital Management first reported a position in Merck in Q1 2022 and has held it in 19 quarters since.
  • Viewpoint Capital Management's Merck position peaked at $467K in Q2 2024.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Viewpoint Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.